Synaptic mitochondrial dysfunction and Alzheimer's disease: from molecular mechanisms to therapeutic strategies.

Wang Y, Wu W, Yan L, Zhang B, Li Q, Zhou Y

Open source

DOI
10.3389/fphar.2026.1849218
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1849218,
  title = {Synaptic mitochondrial dysfunction and Alzheimer's disease: from molecular mechanisms to therapeutic strategies.},
  author = {Wang Y and Wu W and Yan L and Zhang B and Li Q and Zhou Y},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1849218},
  url = {https://doi.org/10.3389/fphar.2026.1849218}
}

RIS

TY  - JOUR
TI  - Synaptic mitochondrial dysfunction and Alzheimer's disease: from molecular mechanisms to therapeutic strategies.
AU  - Wang Y
AU  - Wu W
AU  - Yan L
AU  - Zhang B
AU  - Li Q
AU  - Zhou Y
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1849218
UR  - https://doi.org/10.3389/fphar.2026.1849218
ER  - 

APA

Y, W., W, W., L, Y., B, Z., Q, L., & Y, Z. (2026). Synaptic mitochondrial dysfunction and Alzheimer's disease: from molecular mechanisms to therapeutic strategies.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1849218

Source records